Safety of hypofractionated volumetric modulated arc therapy for early breast cancer: A preliminary report

The present study attempts to evaluate the acute and subacute toxicities of hypofractionated volumetric modulated arc therapy (HFX–VMAT) in patients with early breast cancer (EBC). It is a retrospective analysis of 23 patients treated with HFX–VMAT after breast-conserving surgery between September 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeong Won, Chung, Mi Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320433/
https://www.ncbi.nlm.nih.gov/pubmed/37415628
http://dx.doi.org/10.3892/ol.2023.13916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320433/
https://www.ncbi.nlm.nih.gov/pubmed/37415628
http://dx.doi.org/10.3892/ol.2023.13916

Ejemplares similares